CN112006952A - Application of rose extract extracted by using skin beautifying liquid as extraction solvent - Google Patents
Application of rose extract extracted by using skin beautifying liquid as extraction solvent Download PDFInfo
- Publication number
- CN112006952A CN112006952A CN202010468643.4A CN202010468643A CN112006952A CN 112006952 A CN112006952 A CN 112006952A CN 202010468643 A CN202010468643 A CN 202010468643A CN 112006952 A CN112006952 A CN 112006952A
- Authority
- CN
- China
- Prior art keywords
- less
- skin
- composition
- extraction
- cosmetic liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 58
- 239000000284 extract Substances 0.000 title claims abstract description 50
- 241000220317 Rosa Species 0.000 title claims abstract description 42
- 239000002904 solvent Substances 0.000 title claims abstract description 42
- 239000007788 liquid Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 239000002537 cosmetic Substances 0.000 claims abstract description 50
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 16
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 11
- 229940051250 hexylene glycol Drugs 0.000 claims description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 7
- 150000002314 glycerols Chemical class 0.000 claims description 7
- 229960003237 betaine Drugs 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical group CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims 1
- 229940015975 1,2-hexanediol Drugs 0.000 claims 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims 1
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 1
- 239000003205 fragrance Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 4
- 239000008406 cosmetic ingredient Substances 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 47
- 239000006210 lotion Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- -1 foundation Substances 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 101710088660 Filaggrin Proteins 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102100028314 Filaggrin Human genes 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 238000000956 solid--liquid extraction Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 244000154511 Rosa hybrid cultivar Species 0.000 description 1
- 235000010295 Rosa x kordesii Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- YRVCHYUHISNKSG-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO.OCCCO YRVCHYUHISNKSG-UHFFFAOYSA-N 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Abstract
The present specification discloses the use of a rose extract extracted with a skin cosmetic liquid as an extraction solvent for the preparation of a composition for moisturizing the skin. Specifically, the composition of the present invention comprises a rose extract using an effective and safe extraction solvent, thereby enabling excellent skin safety and usability, and excellent skin moisturizing effect. In addition, the composition of the present invention comprises a rose extract extracted using a skin cosmetic liquid that can be used as a cosmetic ingredient as an extraction solvent, thereby being capable of maintaining the fragrance of rose flowers excellently without additional fragrance.
Description
Technical Field
The present disclosure relates to a skin moisturizing composition comprising rose extract extracted from skin beauty fluid as an extraction solvent as an active ingredient.
Background
Extraction (extraction) is an operation of dissolving only a specific component from a solid or liquid mixture mainly using a liquid solvent to separate the component, and is a very important separation method not only in chemical and biological experiments but also in industry. In this case, chemical reactions such as acid-base or chelate formation are used, or simply the solubility difference can be used. The case of extraction from solids is called solid-liquid extraction, the case of extraction from liquids is called liquid-liquid extraction, and there are also cases where solid-liquid extraction is called leaching.
In the extraction, the solvent extraction refers to the separation of a solid or liquid sample by dissolving one (or two or more in some cases) of the component substances with a solvent. In chemical analysis or using a mixture, there are cases where a component of a certain test material is readily soluble in a specific solvent and other components are insoluble in the solvent.
The extraction solvent refers to a liquid solvent used when a specific substance is dissolved and separated from a solid mixture or a liquid mixture, and water, alcohol, ether, petroleum ether, benzene, ethyl acetate, chloroform, mercury, and the like correspond thereto. Recently, an extraction method using a supercritical fluid (SCF) as a solvent is also frequently used.
Although the extraction thus uses only a solvent, it is also extracted from the mixture by a chemical reaction based on an acid-base reaction or chelate formation. When the solid mixture was extracted with a solvent, a Soxhlet extractor (Soxhlet extractor) was used, and when the liquid mixture was extracted, a separatory funnel was used.
Conventional cosmetic compositions containing plant extracts are used in a method of extracting a raw material by a generally used and widely used extraction method, reducing the raw material again, and putting the reduced raw material into a cosmetic composition. As the extraction method widely used in the above-mentioned fields, there is generally used a method of extracting with an organic solvent, water or a mixture thereof as a solvent, evaporating and removing the solvent from the extracted liquid phase, and then re-processing the solvent into a form usable for cosmetics to use the same for cosmetics.
However, although the use of such a general extraction method is effective in terms of cost and time, there is a possibility that only a component having solubility in a solvent among components having an original substance to be extracted is partially extracted or a part of the component is lost in an evaporation process after extraction. In addition, the organic solvent used may remain in a small amount, and an adverse reaction may occur when the extract is applied to the skin, and for this reason, the skin efficacy of the extract may be reduced, and it may be difficult to perform the function of the cosmetic composition, and there is a possibility that a problem of skin safety may occur.
Disclosure of Invention
An object of one aspect of the present invention is to provide a composition comprising a rose extract using an effective and safe extraction solvent, thereby being excellent in skin safety and usability and excellent in anti-inflammatory and moisturizing effects.
In addition, it is an object of an aspect of the present invention to provide a composition comprising a rose extract extracted using a skin cosmetic liquid that can be used as a cosmetic ingredient as an extraction solvent, thereby excellently maintaining the fragrance of rose flowers without additional fragrance.
In order to achieve the above object, one aspect of the present invention provides a skin moisturizing composition comprising a rose extract extracted from a skin cosmetic liquid as an extraction solvent as an active ingredient.
The composition of one aspect of the present invention comprises a rose extract using an effective and safe extraction solvent, and thus can be excellent in skin safety and usability, and excellent in skin moisturizing effect.
In addition, the composition of an aspect of the present invention includes a rose extract extracted using a skin cosmetic liquid that can be used as a cosmetic ingredient as an extraction solvent, thereby being capable of excellently maintaining the fragrance of rose flowers without additional fragrance.
Drawings
Fig. 1 shows the results of evaluating the skin moisturizing effect of the rose extract of test example 2 of the present invention.
Detailed Description
In the present specification, the term "skin cosmetic liquid" is a generic term for a composition having fluidity which can be applied to the skin for various cosmetic purposes, and mainly includes liquid phase or essential oil type such as soft lotion, nutritional lotion, emulsion, etc., and may include oils, solubilizers, moisturizers, water and other agents.
In the present specification, the term "extract" includes all substances obtained by extracting components of natural products regardless of the extraction method, the extraction solvent, the extracted components, or the form of the extract, and is a broad concept including all substances that can be obtained by processing or treating substances obtained by extracting components of natural products by other methods after extraction, and specifically, the processing or treatment may be additional fermentation or enzymatic treatment of the extract. Therefore, in the present specification, the term "extract" is a broad concept including a fermented product, a concentrated product, and a dried product.
In the present specification, a "glycerol derivative" is a compound similar to glycerol obtained by chemically changing a part of glycerol. Refers to a compound in which a hydrogen atom or a specific atomic group is replaced with another atom or atomic group in glycerin.
The present invention will be described in detail below.
In one aspect, the present invention may relate to a composition for moisturizing skin comprising a rose (Rosa hybrid) flower extract extracted from a skin cosmetic liquid as an extraction solvent as an effective ingredient.
In another aspect, the present invention may relate to the use of a rose extract extracted from a skin cosmetic liquid as an extraction solvent for preparing a composition for moisturizing skin.
As an example, the skin cosmetic liquid may comprise a cosmetic composition consisting of2To C20Diol of (2) and C2To C20More than one selected from the group consisting of trihydric alcohols of (a).
As other examples, the glycol may be one or more selected from the group consisting of butylene glycol, propylene glycol, and hexylene glycol. In addition, the trihydric alcohol may be one or more of glycerin and a glycerin derivative.
As other examples, the butanediol may be 1, 3-butanediol (1,3-butylene glycol), the propanediol may be 1, 3-propanediol (1, 3-propanediol), and the hexanediol may be 1, 2-hexanediol (1, 2-hexandiol).
As another example, the glycerol derivative may be ethylhexylglycerol (ethylhexylglycerol).
As yet another example, the skin cosmetic liquid may include glycerin, butylene glycol, propylene glycol, hexylene glycol, and ethylhexylglycerin.
As yet another example, the skin cosmetic liquid may further include at least one of D-glucose (D-glucose) and betaine (betain).
As an example, the content of the butylene glycol may be 10 to 25% by weight, compared to the total weight of the skin cosmetic liquid. If the amount exceeds 25% by weight, the resulting composition may not be used because of increased viscosity, inability to be filtered, etc., and if the amount is less than 10% by weight, the extraction effect may be significantly reduced. In one aspect, the butylene glycol may be present in an amount of 10 wt% or more, 12 wt% or more, 14 wt% or more, 16 wt% or more, 18 wt% or more, 20 wt% or more, 22 wt% or more, or 24 wt% or more, based on the total weight of the skin cosmetic liquid. The content may be 25 wt% or less, 22 wt% or less, 20 wt% or less, 18 wt% or less, 16 wt% or less, 14 wt% or less, or 12 wt% or less.
As other examples, the propylene glycol may be contained in an amount of 1 to 20% by weight, compared to the total weight of the skin cosmetic liquid. If the amount exceeds 20 wt%, the resulting composition may not be used because of increased viscosity, inability to be filtered, etc., and if the amount is less than 1 wt%, the extraction effect may be significantly reduced. In one aspect, the content may be 1 wt% or more, 4 wt% or more, 6 wt% or more, 8 wt% or more, 10 wt% or more, 12 wt% or more, 14 wt% or more, 16 wt% or more, or 18 wt% or more. The content may be 20 wt% or less, 18 wt% or less, 16 wt% or less, 14 wt% or less, 12 wt% or less, 10 wt% or less, 8 wt% or less, 6 wt% or less, 4 wt% or less, or 2 wt% or less.
As yet another example, the hexylene glycol may be contained in an amount of 0.1 to 5% by weight, compared to the total weight of the skin cosmetic liquid. If the amount exceeds 5 wt%, the resulting composition cannot be used because of increased viscosity, inability to be filtered, etc., whereas if the amount is less than 0.1 wt%, the extraction effect may be significantly reduced. In one aspect, the content may be 0.1 wt% or more, 0.4 wt% or more, 0.6 wt% or more, 0.8 wt% or more, 1 wt% or more, 1.2 wt% or more, 1.5 wt% or more, 2 wt% or more, 2.5 wt% or more, 3 wt% or more, 3.5 wt% or more, 4 wt% or more, or 4.5 wt% or more. The content may be 5 wt% or less, 4.5 wt% or less, 4 wt% or less, 3.5 wt% or less, 3 wt% or less, 2.5 wt% or less, 2 wt% or less, 1.5 wt% or less, 1.2 wt% or less, 1 wt% or less, 0.8 wt% or less, 0.6 wt% or less, 0.4 wt% or less, or 0.2 wt% or less.
As yet another example, the glycerin may be contained in an amount of 5 to 20% by weight, as compared to the total weight of the skin cosmetic liquid. If the amount exceeds 20 wt%, the resulting composition may not be used because of increased viscosity, inability to be filtered, etc., and if the amount is less than 5 wt%, the extraction effect may be significantly reduced. In one aspect, the content may be 5 wt% or more, 7 wt% or more, 9 wt% or more, 11 wt% or more, 13 wt% or more, 15 wt% or more, 17 wt% or more, or 19 wt% or more. The content may be 20 wt% or less, 18 wt% or less, 16 wt% or less, 14 wt% or less, 12 wt% or less, 10 wt% or less, 8 wt% or less, or 6 wt% or less.
As still another example, the content of the glycerin derivative may be 0.01 to 10% by weight, compared to the total weight of the skin cosmetic liquid. If the amount exceeds 10 wt%, the resulting composition may not be used because of increased viscosity, inability to be filtered, etc., and if the amount is less than 0.01 wt%, the extraction effect may be significantly reduced. In one aspect, the content may be 0.01 wt% or more, 0.05 wt% or more, 0.08 wt% or more, 0.1 wt% or more, 0.12 wt% or more, 0.14 wt% or more, 0.2 wt% or more, 0.4 wt% or more, 0.6 wt% or more, 0.8 wt% or more, 1 wt% or more, 4 wt% or more, 6 wt% or more, or 8 wt% or more. Further, the content may be 8 wt% or less, 6 wt% or less, 4 wt% or less, 1 wt% or less, 0.8 wt% or less, 0.6 wt% or less, 0.4 wt% or less, 0.2 wt% or less, 0.14 wt% or less, 0.12 wt% or less, 0.1 wt% or less, 0.08 wt% or less, 0.05 wt% or less, or 0.02 wt% or less.
According to an aspect of the invention, the weight ratio of glycerin to butylene glycol may be 1:0.5 to 5. In one aspect, the ratio may be 1:0.5 or more, 1:0.7 or more, 1:0.9 or more, 1:1.0 or more, 1:1.2 or more, 1:1.4 or more, 1:1.6 or more, 1:1.8 or more, 1:2 or more, 1:2.5 or more, 1:2.8 or more, 1:3 or more, 1:3.5 or more, 1:4 or more, or 1:4.5 or more. The ratio may be 1:5 or less, 1:4.5 or less, 1:4 or less, 1:3.5 or less, 1:3 or less, 1:2.5 or less, 1:2 or less, 1:1.5 or less, 1:1.2 or less, 1:1 or less, 1:0.8 or less, or 1:0.6 or less.
As an example, the weight ratio of butylene glycol to propylene glycol may be 1:0.04 to 2. In one aspect, the ratio may be 1:0.04 or more, 1:0.06 or more, 1:0.08 or more, 1:0.1 or more, 1:0.2 or more, 1:0.4 or more, 1:0.6 or more, 1:0.8 or more, 1:1 or more, 1:1.2 or more, 1:1.4 or more, 1:1.6 or more, or 1:1.8 or more. The ratio may be 1:2 or less, 1:1.8 or less, 1:1.6 or less, 1:1.4 or less, 1:1.2 or less, 1:1 or less, 1:0.8 or less, 1:0.6 or less, 1:0.4 or less, 1:0.2 or less, 1:0.1 or less, 1:0.08 or less, or 1:0.06 or less.
As other examples, the weight ratio of propylene glycol to hexylene glycol may be 1:0.005 to 5. In one aspect, the ratio can be 1:0.005 or more, 1:0.01 or more, 1:0.05 or more, 1:0.1 or more, 1:0.5 or more, 1:1 or more, 1:2 or more, 1:3 or more, or 1:4 or more. The ratio may be 1:5 or less, 1:4 or less, 1:3 or less, 1:2 or less, 1:1 or less, 1:0.5 or less, 1:0.1 or less, 1:0.05 or less, 1:0.01 or less, or 1:0.008 or less.
As other examples, the weight ratio of hexylene glycol to glycerin derivative may be 1:0.002 to 100. In one aspect, the ratio may be 1:0.002 or more, 1:0.005 or more, 1:0.01 or more, 1:0.05 or more, 1:0.1 or more, 1:0.5 or more, 1:1 or more, 1:5 or more, 1:10 or more, 1:20 or more, 1:30 or more, 1:40 or more, 1:50 or more, or 1:80 or more. The ratio may be 1:100 or less, 1:80 or less, 1:60 or less, 1:40 or less, 1:30 or less, 1:20 or less, 1:10 or less, 1:5 or less, 1:1 or less, 1:0.5 or less, 1:0.1 or less, 1:0.05 or less, 1:0.01 or less, or 1:0.005 or less.
As still another example, the content of D-glucose may be 0.1 to 10% by weight, compared to the total weight of the skin cosmetic liquid. If the content exceeds 10 wt%, the use thereof is not possible due to an increase in viscosity, inability to filter, etc., and if it is less than 0.01 wt%, the extraction effect may be significantly reduced. In one aspect, the content of D-glucose may be 0.1 wt% or more, 0.5 wt% or more, 1 wt% or more, 1.5 wt% or more, 2 wt% or more, 2.5 wt% or more, 3 wt% or more, 3.5 wt% or more, 4 wt% or more, 4.5 wt% or more, 5 wt% or more, 5.5 wt% or more, 6 wt% or more, 7 wt% or more, 8 wt% or more, or 9 wt% or more. The content may be 10 wt% or less, 9 wt% or less, 8 wt% or less, 7 wt% or less, 6 wt% or less, 5.5 wt% or less, 5 wt% or less, 4.5 wt% or less, 4 wt% or less, 3.5 wt% or less, 3 wt% or less, 2.5 wt% or less, 2 wt% or less, 1.5 wt% or less, 1 wt% or less, or 0.5 wt% or less.
As yet another example, the betaine may be contained in an amount of 0.1 to 10 wt% compared to the total weight of the skin cosmetic liquid. If the content exceeds 10 wt%, the use thereof is not possible due to an increase in viscosity, inability to filter, etc., and if it is less than 0.01 wt%, the extraction effect may be significantly reduced. In one aspect, the betaine content may be 0.1 wt% or more, 0.5 wt% or more, 1 wt% or more, 1.5 wt% or more, 2 wt% or more, 2.5 wt% or more, 3 wt% or more, 3.5 wt% or more, 4 wt% or more, 4.5 wt% or more, 5 wt% or more, 5.5 wt% or more, 6 wt% or more, 7 wt% or more, 8 wt% or more, or 9 wt% or more. The content may be 10 wt% or less, 9 wt% or less, 8 wt% or less, 7 wt% or less, 6 wt% or less, 5.5 wt% or less, 5 wt% or less, 4.5 wt% or less, 4 wt% or less, 3.5 wt% or less, 3 wt% or less, 2.5 wt% or less, 2 wt% or less, 1.5 wt% or less, 1 wt% or less, or 0.5 wt% or less.
As an example, the rose flower extract may be extracted by ultrasonic extraction, normal temperature extraction, cold soaking extraction, or reflux cooling extraction, but the extraction method is not limited thereto.
As other examples, the rose extract may be extracted at 25 to 30 ℃. For example, the rose extract may be extracted at 25 ℃ or higher, 26 ℃ or higher, 27 ℃ or higher, 28 ℃ or higher, or 29 ℃ or higher, or may be extracted at 30 ℃ or lower, 29 ℃ or lower, 28 ℃ or lower, 27 ℃ or lower, or 26 ℃ or lower.
As yet another example, the rose extract may be extracted for 150 to 210 minutes. For example, the rose extract may be extracted for 150 minutes or more, 160 minutes or more, 170 minutes or more, 180 minutes or more, 190 minutes or more, or 200 minutes or more, or may be extracted for 210 minutes or less, 200 minutes or less, 190 minutes or less, 180 minutes or less, 170 minutes or less, or 160 minutes or less.
As an example, the rose extract may be included in an amount of 1 to 100 wt% compared to the total weight of the composition for the purpose of target effect. As another example, the content of the rose extract may be 1 wt% or more, 5 wt% or more, 10 wt% or more, 15 wt% or more, 20 wt% or more, 30 wt% or more, 40 wt% or more, 50 wt% or more, 60 wt% or more, 70 wt% or more, 80 wt% or more, or 90 wt% or more, as compared to the total weight of the composition, and may be 100 wt% or less, 90 wt% or less, 80 wt% or less, 70 wt% or less, 60 wt% or less, 50 wt% or less, 40 wt% or less, 30 wt% or less, 20 wt% or less, 15 wt% or less, 10 wt% or less, or 5 wt% or less.
As an example, the composition may be a cosmetic composition.
The cosmetic composition of one aspect of the invention may contain a cosmetically or dermatologically acceptable medium or base. It is of all formulations suitable for topical application, and may be provided, for example, in the form of solutions, gels, solids, anhydrous dough products, emulsions obtained by dispersing an oily phase in an aqueous phase, suspensions, microemulsions, microcapsules, finely divided particulate spheres or dispersions of ionic (liposomes) and non-ionic vesicles, or in the form of creams, lotions, emulsions, powders, ointments, sprays or concealer sticks. These compositions may be prepared according to methods common in the art. The cosmetic composition may also be used in the form of an aerosol composition further comprising a propellant compressed into a foam (foam) form.
The cosmetic composition is not particularly limited in its formulation, and may be appropriately selected according to the purpose. For example, it can be formulated into skin lotion, skin softener, skin toner, milky lotion, milk lotion, moisturizing lotion, nourishing lotion, massage cream, nourishing cream, moisturizing cream, hand cream, foundation, essence, nourishing essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, cleansing water, powder, body lotion, body cream, body oil, body wash, body essence, and the like.
When the composition is in the form of a paste, cream or gel, animal fibers, plant fibers, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide can be used as a carrier component.
When the composition is prepared as a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, or the like can be used as a carrier component, and particularly, when the composition is sprayed, a propellant such as chlorofluorocarbon, propane/butane, or dimethyl ether can be added.
When the composition is prepared as a solution or emulsion, a solvent, solubilizer, emulsifier, or the like can be used as the carrier component, and for example, water, ethanol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol oil, glycerol aliphatic ester, polyethylene glycol, or fatty acid ester of sorbitan is present.
When the composition is prepared as a suspension, water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester or polyoxyethylene sorbitol ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, or the like can be used as a carrier component.
When the composition is formulated as a surfactant-containing face cleanser, fatty alcohol sulfate, fatty alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamino betaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, ethoxylated glycerin fatty acid ester, or the like can be used as the carrier component.
In the cosmetic composition, functional additives and ingredients contained in general cosmetic compositions may be additionally included in addition to the rose extract. As the functional supplement, a component selected from the group consisting of water-soluble vitamins, fat-soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids, and seaweed extracts may be included.
In addition, in the composition, components contained in a general cosmetic composition may be combined with the functional additives as needed. Examples of the formulation components to be further contained include an oil component, a humectant, a lubricant, a surfactant, organic and inorganic pigments, organic powders, an ultraviolet absorber, a preservative, a bactericide, an antioxidant, a plant extract, a pH adjuster, alcohol, a pigment, a perfume, a blood circulation promoter, a cold feeling agent, an antiperspirant, purified water, and the like.
The present invention will be described in more detail below with reference to examples and test examples. However, the examples and test examples are only provided for understanding the contents of the present invention, and the scope of the present invention is not limited to the examples and test examples, and modifications, substitutions, and insertions, which are generally known in the art, may be performed, and are also included in the scope of the present invention.
Examples and comparative examples preparation of Rose flower extract
Rose extracts respectively extracted with the extraction solvents of examples 1 and 2 and comparative examples 1 to 5 having the compositions shown in table 1 below were prepared.
Specifically, 0.2g of Rosa damascona (Korea) domestically produced in Korea was immersed in 1kg of the extraction solvent of examples 1 and 2 and comparative examples 1 to 5, respectively, and extracted under reflux at 25 ℃ for 180 minutes, and then filtered through a 0.45 μm filter to prepare a rose extract.
[ Table 1]
Test example 1 evaluation of skin stability and extraction efficiency
The rose extracts extracted with the extraction solvents of examples 1 and 2 and comparative examples 1 to 5 were evaluated for skin stability and extraction efficiency.
Specifically, skin stability was evaluated for 32 healthy adult women with an average age of 36.36 years (people who had removed Psoriasis (Psoriasis), acne (ace), eczema (eczema), other skin diseases, etc. before the test, or pregnant and lactating women, or people who were taking contraceptives, antihistamines, etc.), and a closed patch test (co-site) was performed on each extract. Each extract was applied in an amount of 20 μ l/chamber (IQ chamber), and after 24 hours of patch removal, it was checked for 30 minutes and 24 hours. Skin reactions were evaluated according to the Frosch & Kligman, CTFA guidelines.
In addition, the extraction efficiency was evaluated by comparing the remaining amount (residual) after drying 1g of each sample at 105 ℃ for 4 hours, the more the remaining amount, the higher the extraction amount, and considering whether or not the rose fragrance was maintained (+ ++++: the highest extraction efficiency/+: the lowest extraction efficiency).
The results are shown in table 2 below.
[ Table 2]
From the results of table 2 above, it was confirmed that when examples 1 and 2, which are skin cosmetic liquids of the present invention, were used as extraction solvents, the requirements for skin safety were satisfied, and the extraction efficiency was also excellent, whereas when alcohol, ethyl acetate (ethyl acetate), n-hexane (hexane), or isopropyl alcohol (comparative examples 2 to 5), which are organic solvents widely used in general extraction methods, were used as extraction solvents, the extraction efficiency was high, but the conditions for skin safety were not satisfied. In addition, it was confirmed that when purified water (comparative example 1) was used as the extraction solvent, there was no problem in terms of skin safety, but the extraction efficiency was greatly reduced.
That is, it is understood that examples 1 and 2 of the present invention are combinations of substances usable as cosmetics, and can be used as skin cosmetic liquids (cosmetics) by themselves, and unlike organic solvents such as alcohol, ethyl acetate, n-hexane, and isopropyl alcohol, they are not irritating to the skin and can be used safely, and therefore, they are possible to be applied as cosmetics without solvent removal or additional processing. Therefore, it was confirmed that the extracted rose extract was possible to be directly applied to the skin as a cosmetic composition without additional processing, and thus examples 1 and 2 were significantly superior in terms of usability compared to comparative examples using existing solvents. In addition, in the case of using the above examples 1 and 2 as an extraction solvent, the useful components of roses can be efficiently extracted and the processing process can be minimized, so that the storage stability of the extracted components is remarkably superior to that in the case of using the conventional solvent.
[ test example 2] evaluation of skin moisturizing efficacy of Rose flower extract
The skin moisturizing effect of the rose extracts extracted using the extraction solvents of example 1 and comparative example 1 was evaluated.
Skin moisturizing efficacy was evaluated for the amount of Filaggrin (FLG) gene expression in human keratinocytes (NHEK-neo, Lonza, USA). Specifically, KBM-Gold basal medium (Lonza, USA) supplemented with growth-promoting agent (KGM-Gold Single-Quot Kit, Lonza, USA) was used at 37 deg.C with 5% CO2Under the condition of CO2After culturing human keratinocytes in the medium, the respective rose extract treatments were performed, and after 24 hours, intracellular RNA was isolated using Trizol (Trizol reagent, Invitrogen Carlsbad, CA, USA). The isolated RNA was quantified, and cDNA was synthesized using a Reverse transcription kit (Superscript Reverse Transcriptase (RT) II kit, Invitrogen), and then quantitatively analyzed by real-time polymerase chain reaction (RT-PCR). Use of silk fibroin expression pattern variationGene expression kit (gene expression assay kit) for evaluationAnd (4) price. The results of using the RPLPO gene as an internal control (internal control) gene are shown in fig. 1. In fig. 1% all are weight%.
From the results of fig. 1, it was confirmed that the rose extract of example 1 treated at the same concentration had a predominant expression level of the filaggrin gene compared to the rose extract of comparative example 1 treated at 1 wt%, and that the expression level of the filaggrin gene increased in proportion to the concentration in the case of the rose extract of example 1, and particularly, the expression level of the filaggrin gene significantly increased in the case of example 1 treated at 4 wt%.
[ PREPARATION MODE EXAMPLE 1] nutritious toning lotion
Using example 1 of one aspect of the present invention, 1 wt% of rose was extracted, and 5 wt% (compared to the total weight of the extract) of squalane was added to the extract to prepare a nutritional lotion.
[ PREPARATION EXAMPLE 2] softening toning lotion
Using example 1 of one aspect of the present invention, 5 wt% of rose flowers were extracted, and 0.5 wt% (compared to the total weight of the extract) of liquid paraffin, 5 wt% of caprylic/capric triglyceride, 1.5 wt% of polysorbate 60, 5 wt% of squalane, 4 wt% of wax were added to the extract to prepare a soft lotion.
[ formulation example 3] facial mask
Using example 1 of one aspect of the present invention, 3 wt% of rose flowers were extracted, and a mask was prepared by adding 0.3 wt% (compared to the total weight of the extract) of PEG 12 nonylphenyl ether, 0.1 wt% of allantoin, 13 wt% of polyvinyl alcohol to the extract and applying it to the surface of the mask.
Claims (10)
1. Use of a rose extract extracted with a skin cosmetic liquid as an extraction solvent for preparing a composition for moisturizing skin.
2. The use according to claim 1, wherein,
the skin cosmetic liquid comprises: one or more selected from the group consisting of butylene glycol, propylene glycol and hexylene glycol; and one or more of glycerin and glycerin derivatives.
3. The use according to claim 2, wherein,
the butanediol is 1, 3-butanediol, the propylene glycol is 1, 3-propanediol, and the hexylene glycol is 1, 2-hexanediol.
4. The use according to claim 2, wherein,
the glycerol derivative is ethylhexyl glycerol.
5. The use according to claim 2, wherein,
the skin cosmetic liquid further comprises at least one of D-glucose and betaine.
6. The use according to claim 2, wherein,
the butylene glycol is present in an amount of 10 to 25 wt% compared to the total weight of the skin cosmetic liquid;
the propylene glycol is present in an amount of 1 to 20% by weight, compared to the total weight of the skin cosmetic liquid; or
The content of hexylene glycol is 0.1 to 5% by weight, compared to the total weight of the skin cosmetic liquid.
7. The use according to claim 2, wherein,
the content of glycerin is 5 to 20% by weight compared to the total weight of the skin cosmetic liquid; or
The content of the glycerin derivative is 0.01 to 10% by weight, compared to the total weight of the skin cosmetic liquid.
8. The use according to claim 5, wherein,
the content of D-glucose is 0.1 to 10% by weight compared to the total weight of the skin cosmetic liquid; or
The betaine is contained in an amount of 0.1 to 10 wt% compared to the total weight of the skin cosmetic liquid.
9. The use according to claim 1, wherein,
the rose extract is included in an amount of 1 to 100 wt% compared to the total weight of the composition.
10. The use according to claim 1, wherein,
the composition is a cosmetic composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190063803A KR20200137432A (en) | 2019-05-30 | 2019-05-30 | Composition for skin moisturizing comprising rose flower extract extracted with skin cosmetic solution as a solvent |
KR10-2019-0063803 | 2019-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112006952A true CN112006952A (en) | 2020-12-01 |
Family
ID=73506879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010468643.4A Pending CN112006952A (en) | 2019-05-30 | 2020-05-28 | Application of rose extract extracted by using skin beautifying liquid as extraction solvent |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20200137432A (en) |
CN (1) | CN112006952A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020062513A (en) * | 2001-01-22 | 2002-07-26 | 한국화장품주식회사 | rose petal extract with skin whitening function and skin whitening cosmetic composition containg the same |
JP2006022077A (en) * | 2004-07-05 | 2006-01-26 | Narumi:Kk | External preparation for skin |
US20100303872A1 (en) * | 2009-06-01 | 2010-12-02 | Lvmh Recherche | Use of a polyphenol-rich plant extract as antioxidant in combination with a hydrating or humectant agent |
US20130149322A1 (en) * | 2010-06-07 | 2013-06-13 | Universiteit Leiden | Process for extracting materials from biological material |
JP2018076271A (en) * | 2016-11-11 | 2018-05-17 | 株式会社ファンケル | Estrogen receptor production promoting composition |
CN108478497A (en) * | 2018-06-28 | 2018-09-04 | 广州澳希亚实业有限公司 | A kind of deep water supplement moisture-keeping composition and its application in skin care item |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101394550B1 (en) | 2012-01-19 | 2014-05-13 | 충북대학교 산학협력단 | Anti-bacterial or Anti-inflammatory Composition Comprising Extracts from Flower of Rosa hybrida as Active Ingredient |
-
2019
- 2019-05-30 KR KR1020190063803A patent/KR20200137432A/en not_active Application Discontinuation
-
2020
- 2020-05-28 CN CN202010468643.4A patent/CN112006952A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020062513A (en) * | 2001-01-22 | 2002-07-26 | 한국화장품주식회사 | rose petal extract with skin whitening function and skin whitening cosmetic composition containg the same |
JP2006022077A (en) * | 2004-07-05 | 2006-01-26 | Narumi:Kk | External preparation for skin |
US20100303872A1 (en) * | 2009-06-01 | 2010-12-02 | Lvmh Recherche | Use of a polyphenol-rich plant extract as antioxidant in combination with a hydrating or humectant agent |
US20130149322A1 (en) * | 2010-06-07 | 2013-06-13 | Universiteit Leiden | Process for extracting materials from biological material |
JP2018076271A (en) * | 2016-11-11 | 2018-05-17 | 株式会社ファンケル | Estrogen receptor production promoting composition |
CN108478497A (en) * | 2018-06-28 | 2018-09-04 | 广州澳希亚实业有限公司 | A kind of deep water supplement moisture-keeping composition and its application in skin care item |
Also Published As
Publication number | Publication date |
---|---|
KR20200137432A (en) | 2020-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10639269B2 (en) | Cosmetic compositions comprising tobacco seed-derived component | |
WO2014037529A9 (en) | Anti-dandruff composition | |
CN112006953A (en) | Application of folium Artemisiae Argyi extract extracted with skin caring liquid as extraction solvent | |
KR102323998B1 (en) | Cosmetic composition containing hibiscus flower extracts and hibiscus fruit extracts and preparation method for the same | |
CN107412031B (en) | Skin external composition containing hesperetin | |
JPH09328410A (en) | Cosmetic and its production | |
JPH0873324A (en) | Hair-tonic and hair-growing agent | |
JP4489923B2 (en) | Topical skin preparation | |
EP1861486B1 (en) | A process of preparing jambu extract, use of said extract, cosmetic compositions comprising thereof and cosmetic products comprising said cosmetic compositions | |
JP4866501B2 (en) | Topical skin preparation | |
JPH06271452A (en) | Skin cosmetic containing extract of plant of cactuses | |
CN112006952A (en) | Application of rose extract extracted by using skin beautifying liquid as extraction solvent | |
JP4080371B2 (en) | Cosmetics | |
KR102076179B1 (en) | A cosmetic composition for alleviating skin irritation by vitamin c containing a mixed extract of iris lactea and doellingeria scabra | |
WO2017119143A1 (en) | Skin external agent | |
JP2000159653A (en) | Preparation for external use for skin | |
KR20220026746A (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Chaenomeles sinensis fruit, Diospyros kaki leaf, Cinnamomum cassia bark, Artemisia princeps leaf, Chrysanthellum indicum and Camellia sinensis leaf as Active Ingredient | |
JPH09143025A (en) | Cosmetic | |
KR20210037362A (en) | Cosmetic Compostion For Moisturizing Skin Comprising Mixed Extracts of Chondrus crispus, Origanum majorana, Petroselinum crispum and Fumaria officinalis As Active Ingredient | |
JP4233732B2 (en) | Cosmetics | |
KR102711520B1 (en) | Enzyme-treated product of tulipa gesneriana with excellent skin moisturizing effect and barrier effect and a cosmetic composition comprising the same | |
JP4577596B2 (en) | Hair restorer or hair growth agent and method of use thereof | |
KR102656826B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Opuntia Tuna Fruit, Thuja Occidentalis Leaf and Lilium Candidum Bulb | |
JP5156281B2 (en) | Antioxidant and cosmetic composition | |
JP2010241715A (en) | Neutral endopeptidase inhibitor and hair growth inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40033016 Country of ref document: HK |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |